SENATE Oil Reserve

The Senate voted, 98 to 1, to continue filling the Strategic Petroleum Reserve for four more years. The reserve's authorization is due to expire June 30. The reserve contains about 490 million barrels of oil, enough to sustain the United States for about 108 days. The Reagan administration wants to stop filling the reserve temporarily. The Senate rejected, 55 to 45, a proposal that would have given states emergency grants to help the poor pay heating bills in the event of high prices during an oil shortage. (HR1699; June 18) NOAA Funds

By voice vote, the Senate passed a $742.2 million authorization for the Commerce Department's National Oceanic and Atmospheric Administration for fiscal 1986. The bill would freeze NOAA programs at fiscal 1985 levels except for satellite systems, which would receive $276.7 million, a $74 million increase. The increase would provide funds to improve NOAA's geostationary weather satellites, one of which failed last year. The bill also includes $287.6 million for weather forecasting systems. (S1103; June 18) Farm Shipments

The Commerce Committee rejected, 9 to 7, legislation that would have exempted government-financed farm exports from a law that requires half of U.S. government cargo to be shipped on U.S. vessels. The Agriculture Committee has approved the measure, and a compromise must be worked out before it reaches the Senate floor. Critics of the "cargo preference" provision say it serves special interests and hampers agricultural exports. (S721; June 19) Line-Item Veto

The Rules Committee rejected legislation that would have given the president power to veto individual items in appropriations bills, a pet idea of President Reagan. Under current law, a president may veto only entire bills. The panel, by a 10-to-0 vote, sent the bill to the floor with an unfavorable report. Reagan contends that the line-item veto would help him cut government spending. (S43; June 20) HOUSE Drinking Water

By voice vote, the House passed legislation that would extend the Safe Drinking Water Act for four more years, authorizing $114 million annually for fiscal 1986 and 1987 and $142 million a year for fiscal 1988 and 1989. The bill contains a provision, opposed by the administration, that would require the Environmental Protection Agency to set limits for certain drinking-water contaminants within three years. The bill also would require states to prepare plans within three years to protect underground sources of drinking water. The Senate bill, passed May 16, would authorize $131 million annually for fiscal 1986-89 and also would require the EPA to set standards to regulate the contaminants. (HR1650; June 17) Health Institutes

Despite the threat of a presidential veto, the House passed, by voice vote, a bill that would establish two new institutes -- one for arthritis, the other for nursing -- at the National Institutes of Health. The bill would also authorize $1.35 billion for the National Cancer Institute for fiscal 1986, a $149 million increase, and would authorize $870 million in fiscal 1986 for the National Heart, Lung and Blood Institute. Reagan vetoed a similar measure in October, and the White House has threatened another veto this year. (HR2409; June 17) Family Planning

The House rejected a $142.5 million authorization for Title X family-planning services, the amount Congress appropriated in fiscal 1985. The vote was 213 to 197 in favor of the bill, but that was short of the two-thirds vote required for passage under the special procedures that brought the bill to the floor. The measure, which will be brought to the floor for another vote later this year, also would have authorized $151 million for fiscal 1987 and $160 million for fiscal 1988. The bill, which provides grants to about 4,500 family-planning clinics, would have continued to ban the use of the funds for abortions. The administration opposes the bill as too costly. (HR2369; June 18) 'Orphan' Drugs

The House, by a 413-to-0 vote, approved legislation that would authorize $4 million a year in grants for fiscal 1986-88 to encourage the production of "orphan" drugs. These drugs are not very profitable for pharmaceutical companies because they are used to treat relatively rare diseases. The measure also would allow the Food and Drug Administration to grant seven-year exclusive -- marketing rights for orphan drugs. (HR2290; June 18)